Send to

Choose Destination
Biochemistry. 2018 Dec 6. doi: 10.1021/acs.biochem.8b00827. [Epub ahead of print]

Next-generation PNA chimeras exhibit high affinity and potent gene silencing.


We present a new design of mixed-backbone antisense oligonucleotides (ASOs) containing both DNA and peptide nucleic acid (PNA). Previous generations of PNA-DNA chimeras showed low binding affinity, reducing their potential as therapeutics. The addition of a 5'-wing of locked nucleic acid as well as the combination of modified nucleotide and PNA monomer at the junction between PNA and DNA gave high affinity to the chimeras. The resulting ASOs demonstrated high serum stability and elicited robust RNase H-mediated cleavage of complementary RNA. These properties allowed the chimeric ASOs to demonstrate high gene silencing efficacy and potency in cells, comparable with LNA gapmer ASOs, both by lipid transfection and gymnosis.

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center